Literature DB >> 15891558

Cross-sectional study of bone mineral density in adult survivors of solid pediatric cancers.

Jennifer Kelly1, Timothy Damron, William Grant, Christopher Anker, Sean Holdridge, Susan Shaw, Jason Horton, Irene Cherrick, Joseph Spadaro.   

Abstract

To investigate the hypothesis that survivors of pediatric solid cancer have low bone mineral density, a cross-sectional study was done of subjects who had received treatment for pediatric solid tumors before 16 years of age and were less than 40 years old at follow-up. Excluded were subjects treated for acute lymphoblastic leukemia or those who had received cranial irradiation, total body radiation, or nonautologous bone marrow transplant. The study group consisted of 38 subjects, with the most common diagnoses being lymphoma (n = 17), sarcoma (n = 8), Wilms tumor (n = 5), and neuroblastoma (n = 4). Median age was 22 years (range 12-32). Time from diagnosis of underlying cancer averaged 12.6 years (range 5.5-20.3). Using criteria of osteopenia (Z-score < or = -1.0 and > -2.0) and osteoporosis (Z-score < or = -2.0) for any one or more areas including total body, lumbar spine, total hip, or femoral neck density, 13 of the 38 subjects (34%) had osteopenia or osteoporosis. A further six subjects (16%) had isolated upper extremity osteopenia or osteoporosis. Multivariate analysis showed a direct relationship between the number of chemotherapy drugs administered and the presence of osteopenia or osteoporosis in the lower extremities (P = 0.03). Young survivors of childhood solid tumors are at increased risk of developing premature osteopenia or osteoporosis, and screening evaluations and follow-up are warranted.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15891558     DOI: 10.1097/01.mph.0000162526.77400.78

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN: 1077-4114            Impact factor:   1.289


  16 in total

1.  Differential diagnosis and work-up of elevations of alkaline phosphatase following therapy for pediatric cancer.

Authors:  Jessica R Roberson; Sue C Kaste; Victor M Santana; Wayne L Furman
Journal:  Pediatr Blood Cancer       Date:  2008-12       Impact factor: 3.167

2.  Use of dual energy X-ray absorptiometry in pediatric patients.

Authors:  Halley Wasserman; Jennifer M O'Donnell; Catherine M Gordon
Journal:  Bone       Date:  2016-12-15       Impact factor: 4.398

3.  Parathyroid hormone attenuates radiation-induced increases in collagen crosslink ratio at periosteal surfaces of mouse tibia.

Authors:  Megan E Oest; Bo Gong; Karen Esmonde-White; Kenneth A Mann; Nicholas D Zimmerman; Timothy A Damron; Michael D Morris
Journal:  Bone       Date:  2016-03-04       Impact factor: 4.398

4.  Predictors of bone loss in childhood hematologic malignancies: a prospective study.

Authors:  Ghada El-Hajj Fuleihan; S Muwakkit; A Arabi; L E-O Daouk; T Ghalayini; J Chaiban; M Abboud
Journal:  Osteoporos Int       Date:  2011-04-08       Impact factor: 4.507

5.  Changes in health status among aging survivors of pediatric upper and lower extremity sarcoma: a report from the childhood cancer survivor study.

Authors:  Neyssa Marina; Melissa M Hudson; Kendra E Jones; Daniel A Mulrooney; Raffi Avedian; Sarah S Donaldson; Rita Popat; Dee W West; Paul Fisher; Wendy Leisenring; Marilyn Stovall; Leslie L Robison; Kirsten K Ness
Journal:  Arch Phys Med Rehabil       Date:  2013-02-01       Impact factor: 3.966

6.  Pediatric Hodgkin lymphoma survivors at negligible risk for significant bone mineral density deficits.

Authors:  Sue C Kaste; Monika L Metzger; Anum Minhas; Zang Xiong; Shesh N Rai; Kirsten K Ness; Melissa M Hudson
Journal:  Pediatr Blood Cancer       Date:  2009-04       Impact factor: 3.167

7.  Do long term survivors of ewing family of tumors experience low bone mineral density and increased fracture risk?

Authors:  Gerhard M Hobusch; Iris Noebauer-Huhmann; Christoph Krall; Gerold Holzer
Journal:  Clin Orthop Relat Res       Date:  2014-07-12       Impact factor: 4.176

Review 8.  Cancer treatment-related bone disease.

Authors:  Sue A Brown; Theresa A Guise
Journal:  Crit Rev Eukaryot Gene Expr       Date:  2009       Impact factor: 1.807

9.  Raman spectroscopy demonstrates prolonged alteration of bone chemical composition following extremity localized irradiation.

Authors:  Bo Gong; Megan E Oest; Kenneth A Mann; Timothy A Damron; Michael D Morris
Journal:  Bone       Date:  2013-08-23       Impact factor: 4.398

10.  An osteoporotic hip fracture in a 14-year-old girl undergoing chemotherapy and operated for knee osteosarcoma.

Authors:  Carmine Zoccali; Umberto Prencipe; Virginia Ferraresi; Nicola Salducca
Journal:  J Orthop Traumatol       Date:  2009-07-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.